Medicines for Malaria Venture and Anacor Pharmaceuticals Announce Collaboration to Apply Boron Chemistry Technology to …
PALO ALTO, Calif. & GENEVA—-Anacor Pharmaceuticals today announced that it has entered into a research agreement with not-for-profit Medicines for Malaria Venture to explore Anacor’s novel boron chemistry platform for developing new therapeutics for the treatment of malaria.

Read more on Business Wire via Yahoo! Finance